Mingxia X. Yan

Shanghai, China

Last Updated: 09/26/2026

Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 30 publications

Targeting the PARP10-BCAT2 axis disrupts branched-chain amino-acid metabolism to suppress bone metastasis in lung cancer.

Targeting the PARP10-BCAT2 axis disrupts branched-chain amino-acid metabolism to suppress bone metastasis in lung cancer.

Journal: Cell death & disease
Published: December 29, 2025

PCGF1-mediated bivalent promoter remodeling enables NK cell immune evasion in non-small cell lung cancer.

PCGF1-mediated bivalent promoter remodeling enables NK cell immune evasion in non-small cell lung cancer.

Journal: Cell death & disease
Published: December 08, 2025

U2AF2-regulated alternative splicing of UPP1 promotes NSCLC progression by enhancing glycolysis.

U2AF2-regulated alternative splicing of UPP1 promotes NSCLC progression by enhancing glycolysis.

Journal: Cell communication and signaling : CCS
Published: December 03, 2025

Proteomic landscape analysis of undifferentiated pleomorphic sarcoma.

Proteomic landscape analysis of undifferentiated pleomorphic sarcoma.

Journal: Genome medicine
Published: October 31, 2025

Research progress on biomarkers for proficient mismatch repair/microsatellite stable colorectal cancer in the immunotherapy era

Research progress on biomarkers for proficient mismatch repair/microsatellite stable colorectal cancer in the immunotherapy era

Journal: Zhonghua wei chang wai ke za zhi = Chinese journal of gastrointestinal surgery
Published: July 24, 2025

Establishment and comprehensive characterization of a subline with highly bone-metastatic propensity derived from the lung adenocarcinoma A549 cell line.

Establishment and comprehensive characterization of a subline with highly bone-metastatic propensity derived from the lung adenocarcinoma A549 cell line.

Journal: Journal of bone oncology
Published: July 16, 2025

TENT5A mediates the cancer-inhibiting effects of EGR1 by suppressing the protein stability of RPL35 in hepatocellular carcinoma.

TENT5A mediates the cancer-inhibiting effects of EGR1 by suppressing the protein stability of RPL35 in hepatocellular carcinoma.

Journal: Cellular oncology (Dordrecht, Netherlands)
Published: November 09, 2024

RBIS regulates ribosome biogenesis to affect progression in lung adenocarcinoma.

RBIS regulates ribosome biogenesis to affect progression in lung adenocarcinoma.

Journal: Journal of translational medicine
Published: March 28, 2024

KLRB1 expression is associated with lung adenocarcinoma prognosis and immune infiltration and regulates lung adenocarcinoma cell proliferation and metastasis through the MAPK/ERK pathway.

KLRB1 expression is associated with lung adenocarcinoma prognosis and immune infiltration and regulates lung adenocarcinoma cell proliferation and metastasis through the MAPK/ERK pathway.

Journal: Journal of thoracic disease
Published: January 02, 2024

Single-cell landscape of undifferentiated pleomorphic sarcoma.

Single-cell landscape of undifferentiated pleomorphic sarcoma.

Journal: Oncogene
Published: August 24, 2023

CDK12 loss inhibits cell proliferation by regulating TBK1 in non-small cell lung cancer cells.

CDK12 loss inhibits cell proliferation by regulating TBK1 in non-small cell lung cancer cells.

Journal: Molecular and cellular probes
Published: March 23, 2023

DYNC1H1 regulates NSCLC cell growth and metastasis by IFN-γ-JAK-STAT signaling and is associated with an aberrant immune response.

DYNC1H1 regulates NSCLC cell growth and metastasis by IFN-γ-JAK-STAT signaling and is associated with an aberrant immune response.

Journal: Experimental cell research
Published: June 08, 2021
Showing 1-12 of 30

Last Updated: 09/26/2026